FEM1A

FEM1A
Identifiers
Aliases	FEM1A, EPRAP, fem-1 homolog A
External IDs	OMIM: 613538 MGI: 1335089 HomoloGene: 7713 GeneCards: FEM1A
Gene location (Human) Chr. Chromosome 19 (human) Band 19p13.3 Start 4,791,734 bp End 4,801,273 bp
Gene location (Mouse) Chr. Chromosome 17 (mouse) Band 17 D|17 29.24 cM Start 56,563,810 bp End 56,570,610 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in tibialis anterior muscle quadriceps femoris muscle vastus lateralis muscle biceps brachii deltoid muscle body of tongue right ventricle gastrocnemius muscle cerebellar vermis superior surface of tongue Top expressed in extensor digitorum longus muscle plantaris muscle gastrocnemius muscle triceps brachii muscle tibialis anterior muscle temporal muscle skeletal muscle tissue thoracic diaphragm sternocleidomastoid muscle digastric muscle More reference expression data BioGPS n/a
Gene ontology Molecular function EP4 subtype prostaglandin E2 receptor binding ubiquitin-protein transferase activity Cellular component cytoplasm cytosol Biological process negative regulation of inflammatory response protein ubiquitination regulation of ubiquitin-protein transferase activity post-translational protein modification Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 55527 14154 Ensembl ENSG00000141965 ENSMUSG00000043683 UniProt Q9BSK4 Q9Z2G1 RefSeq (mRNA) NM_018708 NM_010192 RefSeq (protein) NP_061178 NP_034322 Location (UCSC) Chr 19: 4.79 – 4.8 Mb Chr 17: 56.56 – 56.57 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Fem-1 homolog A is a protein that in humans is encoded by the FEM1A gene.

Further reading

• Ventura-Holman T, Hahn H, Subauste JS, Maher JF (2005). "The Fem1a gene is downregulated in Rhabdomyosarcoma". Tumour Biol. 26 (6): 294–9. doi:10.1159/000089261. PMID 16254458. S2CID 2202410.
• Maher JF, Hines RS, Futterweit W, Crawford S, Lu D, Shen P, Oefner P, Kazi M, Wilson JG, Subauste JS, Cowan BD (December 2005). "FEM1A is a candidate gene for polycystic ovary syndrome". Gynecol. Endocrinol. 21 (6): 330–5. doi:10.1080/09513590500431458. PMID 16390781. S2CID 24793473.
• Minami M, Shimizu K, Okamoto Y, Folco E, Ilasaca ML, Feinberg MW, Aikawa M, Libby P (April 2008). "Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation". J. Biol. Chem. 283 (15): 9692–703. doi:10.1074/jbc.M709663200. PMC 2442287. PMID 18270204.
• Goodarzi MO, Maher JF, Cui J, Guo X, Taylor KD, Azziz R (December 2008). "FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome". Hum. Reprod. 23 (12): 2842–9. doi:10.1093/humrep/den324. PMC 2583941. PMID 18757445.
• Goodarzi MO, Maher JF, Cui J, Guo X, Taylor KD, Azziz R (December 2008). "FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome". Hum. Reprod. 23 (12): 2842–9. doi:10.1093/humrep/den324. PMC 2583941. PMID 18757445.
• Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD (November 2009). "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip". Am. J. Hum. Genet. 85 (5): 628–42. doi:10.1016/j.ajhg.2009.10.014. PMC 2775832. PMID 19913121.
• McGeachie M, Ramoni RL, Mychaleckyj JC, Furie KL, Dreyfuss JM, Liu Y, Herrington D, Guo X, Lima JA, Post W, Rotter JI, Rich S, Sale M, Ramoni MF (December 2009). "Integrative predictive model of coronary artery calcification in atherosclerosis". Circulation. 120 (24): 2448–54. doi:10.1161/CIRCULATIONAHA.109.865501. PMC 2810344. PMID 19948975.
• Ewens KG, Stewart DR, Ankener W, Urbanek M, McAllister JM, Chen C, Baig KM, Parker SC, Margulies EH, Legro RS, Dunaif A, Strauss JF, Spielman RS (May 2010). "Family-based analysis of candidate genes for polycystic ovary syndrome". J. Clin. Endocrinol. Metab. 95 (5): 2306–15. doi:10.1210/jc.2009-2703. PMC 2869537. PMID 20200332.
• Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S (October 2010). "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study". Diabetes Care. 33 (10): 2250–3. doi:10.2337/dc10-0452. PMC 2945168. PMID 20628086.